Bukwang Pharm Net Asset Quality Index
Bukwang Pharm net asset quality index. Bukwang Pharm (003000) has a Net Asset Quality Index of 72.1% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩472.99 Billion minus total liabilities of ₩132.16 Billion yields net assets of ₩340.83 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See what is Bukwang Pharm's book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Bukwang Pharm (2007–2024)
Net asset quality index of Bukwang Pharm from 2007 to 2024. This chart shows how Bukwang Pharm's Net Asset Quality Index has evolved across 14 annual periods from 2007 to 2024. As of September 2025, the index stands at 72.1%, representing net assets of ₩340.83 Billion against total assets of ₩472.99 Billion KRW. Check Bukwang Pharm PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Bukwang Pharm Net Asset Quality Index by Year (2007–2024)
Bukwang Pharm net asset quality index by year from 2007 to 2024. The table below presents the year-by-year Net Asset Quality Index for Bukwang Pharm from 2007 to 2024, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Bukwang Pharm (003000) total market value.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 65.4% | ₩244.15 Billion | ₩373.18 Billion | ₩129.03 Billion | ▲ +10.8 pp |
| 2023 | 54.6% | ₩234.26 Billion | ₩429.02 Billion | ₩194.75 Billion | ▼ -13.2 pp |
| 2022 | 67.8% | ₩271.85 Billion | ₩400.93 Billion | ₩129.08 Billion | ▼ -2.7 pp |
| 2021 | 70.5% | ₩280.06 Billion | ₩397.42 Billion | ₩117.36 Billion | ▲ +2.8 pp |
| 2020 | 67.6% | ₩271.19 Billion | ₩400.97 Billion | ₩129.78 Billion | ▼ -16.4 pp |
| 2019 | 84.0% | ₩326.49 Billion | ₩388.53 Billion | ₩62.05 Billion | ▲ +0.3 pp |
| 2018 | 83.8% | ₩413.44 Billion | ₩493.62 Billion | ₩80.17 Billion | ▼ -5.7 pp |
| 2017 | 89.4% | ₩211.30 Billion | ₩236.23 Billion | ₩24.93 Billion | ▼ -0.9 pp |
| 2016 | 90.3% | ₩214.63 Billion | ₩237.63 Billion | ₩23.00 Billion | ▲ +1.6 pp |
| 2015 | 88.8% | ₩225.15 Billion | ₩253.66 Billion | ₩28.51 Billion | ▲ +0.1 pp |
| 2014 | 88.7% | ₩210.00 Billion | ₩236.82 Billion | ₩26.82 Billion | ▲ +0.6 pp |
| 2013 | 88.1% | ₩201.07 Billion | ₩228.21 Billion | ₩27.14 Billion | ▲ +12.6 pp |
| 2008 | 75.5% | ₩174.01 Billion | ₩230.55 Billion | ₩56.54 Billion | ▼ -3.9 pp |
| 2007 | 79.4% | ₩170.63 Billion | ₩215.02 Billion | ₩44.39 Billion | — |